title: Evolution of brain-derived neurotrophic factor levels after autologous hematopietic stem cell transplantation in multiple sclerosis.
abstract: A neuroprotective role of inflammation has been suggested based on that immune cells are the main source of brain-derived neurotrophic factor (BDNF). We investigated the 3-year evolution of BDNF levels in serum, CSF and culture supernatant of peripheral blood mononuclear cells (PBMC), unstimulated and stimulated with anti-CD3 and soluble anti-CD28 antibodies, in 14 multiple sclerosis patients who underwent an autologous hematopoietic stem cell transplantation (AHSCT). BDNF levels were correlated with previously reported MRI measures that showed a reduction of T2 lesion load and increased brain atrophy, mainly at first year post-transplant. A significant decrease of serum BDNF levels was seen at 12 months post-transplant. BDNF values were found significantly lower in stimulated but not in unstimulated PBMC supernatants during the follow-up, supporting that AHSCT may induce a down-regulation of BDNF production. The only significant correlation was found between CSF BDNF levels and T2 lesion load before and 1 year after AHSCT, suggesting that BDNF reflects the past and ongoing inflammatory activity and demyelination of these highly active patients. Our study suggests that AHSCT can reduce BDNF levels to values associated with lower activity. This decrease does not seem to correlate with the brain atrophy measures observed in the MRI.
authors.affiliation: Services of Neurology, Hospital Clínic, Villarroel 170, Barcelona 08036, Spain.
authors.forename: Y
authors.initials: Y
authors.lastname: Blanco
authors.forename: A
authors.initials: A
authors.lastname: Saiz
authors.forename: M
authors.initials: M
authors.lastname: Costa
authors.forename: J F
authors.initials: JF
authors.lastname: Torres-Peraza
authors.forename: E
authors.initials: E
authors.lastname: Carreras
authors.forename: J
authors.initials: J
authors.lastname: Alberch
authors.forename: D
authors.initials: D
authors.lastname: Jaraquemada
authors.forename: F
authors.initials: F
authors.lastname: Graus
mesh_terms: D000906:Antibodies / Q000494:pharmacology; D005075:Biological Evolution; D001921:Brain / Q000378:metabolism* / Q000473:pathology; D019208:Brain-Derived Neurotrophic Factor / Q000097:blood / Q000134:cerebrospinal fluid; D018106:CD28 Antigens / Q000276:immunology; D017252:CD3 Complex / Q000276:immunology; D002478:Cells, Cultured; D016207:Cytokines / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005500:Follow-Up Studies; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007962:Leukocytes / Q000187:drug effects / Q000378:metabolism; D008279:Magnetic Resonance Imaging / Q000379:methods; D009103:Multiple Sclerosis / Q000097:blood / Q000134:cerebrospinal fluid / Q000628:therapy*; D013223:Statistics as Topic; D013997:Time Factors
chemical_list: D000906:Antibodies; D019208:Brain-Derived Neurotrophic Factor; D018106:CD28 Antigens; D017252:CD3 Complex; D016207:Cytokines